Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Boehringer Ingelheim donates vaccines to fight rabies in Puerto Rico
"We’re pleased to do our part to help protect animals from rabies" - Randolph Legg, Boehringer Ingelheim.

Rabies is estimated to kill some 59,000 humans annually

Pharmaceutical firm Boehringer Ingelheim has pledged to donate 60,000 doses of its rabies vaccine over the next three years to help fight the disease in Puerto Rico.


The firm announced the move to coincide with World Rabies Day (28 September) as part of its Shots for Good Initiative to help eradicate rabies around the world by vaccinating dogs.


“We’re pleased to do our part to help protect animals from rabies,” said Randolph Legg, head of the pet vet business at Boehringer Ingelheim’s U.S. animal health business.

Rabies is estimated to kill some 59,000 humans annually in more than 150 countries and regions. Dog bites are the main source of human death, accounting for more than 99 per cent of transmission of rabies from animals to people. 


Boehringer announced that it will spread the donations in Puerto Rico over three years alongside events planned by the Spayathon for Puerto Rico, a coalition of around 24 groups organised by the Humane Society of the United States. The groups have offered to provide spay/neuter and vaccination services to thousands of animals.

The nonprofit Veterinarians for Puerto Rico will use the donated vaccines to protect animals in rural parts of the island. Boehringer also said it will donate tens of thousands of dollars to the nonprofit Greatergood.org, which provides proof of rabies vaccination for animal shelters and unserved communities in need.


Chief executive Louis Nel of the Global Alliance for Rabies Control, which coordinates World Rabies Day, said the world is moving toward eliminating rabies deaths by 2030.


“The most important element of any rabies-elimination program is the vaccination of animals and humans, and is reflected by this year’s World Rabies Day theme: ‘Rabies: Vaccinate to Eliminate.’ The involvement and collaboration of vaccine manufacturers is essential to help countries on their journey towards freedom from rabies.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.